These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 28232214)

  • 1. Reduced susceptibility to cefixime but not ceftriaxone: an uncertain perspective for the treatment of gonorrhoea in Brazil.
    Costa-Lourenço APR; Abrams JA; Barros Dos Santos KT; Coelho-Souza T; Moreira BM; Fracalanzza SEL; Trees DL; Bonelli RR
    Int J Antimicrob Agents; 2017 Apr; 49(4):515-516. PubMed ID: 28232214
    [No Abstract]   [Full Text] [Related]  

  • 2. Neisseria gonorrhoeae Resistant to Ceftriaxone and Cefixime, Argentina.
    Gianecini R; Oviedo C; Stafforini G; Galarza P
    Emerg Infect Dis; 2016 Jun; 22(6):1139-41. PubMed ID: 27191699
    [No Abstract]   [Full Text] [Related]  

  • 3. Cephalosporin-Resistant Neisseria gonorrhoeae Isolated in Portugal, 2019.
    Pinto M; Matias R; Rodrigues JC; Duarte S; Vieira L; Gonçalves I; Gonçalves MJ; Ramos MH; Gomes JP; Borrego MJ
    Sex Transm Dis; 2020 Nov; 47(11):e54-e56. PubMed ID: 32530860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergence and Spread of Neisseria gonorrhoeae Isolates With Decreased Susceptibility to Extended-Spectrum Cephalosporins in Argentina, 2009 to 2013.
    Gianecini R; Romero MLM; Oviedo C; Vacchino M; Galarza P;
    Sex Transm Dis; 2017 Jun; 44(6):351-355. PubMed ID: 28499284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations of the pilQ gene in Neisseria gonorrhoeae are unlikely contributors to decreased susceptibility to ceftriaxone and cefixime in clinical gonococcal strains.
    Whiley DM; Jacobsson S; Tapsall JW; Nissen MD; Sloots TP; Unemo M
    J Antimicrob Chemother; 2010 Dec; 65(12):2543-7. PubMed ID: 20940180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in the six most common sequence types of Neisseria gonorrhoeae, including ST4378, identified by surveillance of antimicrobial resistance in northern Taiwan from 2006 to 2013.
    Cheng CW; Li LH; Su CY; Li SY; Yen MY
    J Microbiol Immunol Infect; 2016 Oct; 49(5):708-716. PubMed ID: 25442864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Notes from the Field: First Case in the United States of Neisseria gonorrhoeae Harboring Emerging Mosaic penA60 Allele, Conferring Reduced Susceptibility to Cefixime and Ceftriaxone.
    Picker MA; Knoblock RJ; Hansen H; Bautista I; Griego R; Barber L; Bendik W; Lam K; Adelman E; Qiu-Shultz Z; Raphael BH; Pham CD; Kersh EN; Weinstock H; St Cyr SB
    MMWR Morb Mortal Wkly Rep; 2020 Dec; 69(49):1876-1877. PubMed ID: 33301430
    [No Abstract]   [Full Text] [Related]  

  • 8. Antimicrobial Susceptibility Evaluation and Multiple-Locus Variable Number Tandem Repeat Analysis of Neisseria gonorrhoeae Isolates in China in 2012.
    Yu RX; Yin Y; Dai XQ; Chen SC; Han Y; Zheng BJ; Zhang GY; Chen XS
    Sex Transm Dis; 2017 Apr; 44(4):197-201. PubMed ID: 28282644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging azithromycin-resistance among the Neisseria gonorrhoeae strains isolated in Hungary.
    Brunner A; Nemes-Nikodem E; Jeney C; Szabo D; Marschalko M; Karpati S; Ostorhazi E
    Ann Clin Microbiol Antimicrob; 2016 Sep; 15(1):53. PubMed ID: 27646968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unique combined penA/mtrR/porB mutations and NG-MAST strain types associated with ceftriaxone and cefixime MIC increases in a 'susceptible' Neisseria gonorrhoeae population.
    Thakur SD; Starnino S; Horsman GB; Levett PN; Dillon JR
    J Antimicrob Chemother; 2014 Jun; 69(6):1510-6. PubMed ID: 24532681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased susceptibility to cephalosporins among gonococci: data from the Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP) in England and Wales, 2007-2011.
    Ison CA; Town K; Obi C; Chisholm S; Hughes G; Livermore DM; Lowndes CM;
    Lancet Infect Dis; 2013 Sep; 13(9):762-8. PubMed ID: 23764300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gonorrhoea treatment failures to cefixime and azithromycin in England, 2010.
    Ison CA; Hussey J; Sankar KN; Evans J; Alexander S
    Euro Surveill; 2011 Apr; 16(14):. PubMed ID: 21492528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial resistance of Neisseria gonorrhoeae in Germany: low levels of cephalosporin resistance, but high azithromycin resistance.
    Buder S; Dudareva S; Jansen K; Loenenbach A; Nikisins S; Sailer A; Guhl E; Kohl PK; Bremer V;
    BMC Infect Dis; 2018 Jan; 18(1):44. PubMed ID: 29343220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gonococcal susceptibility to cephalosporins--Hawaii, 2003 to 2011.
    Kidd S; Lee MV; Maningas E; Komeya A; Kunimoto G; O'Connor N; Katz AR; Wasserman GM; Kirkcaldy RD; Whelen AC
    Sex Transm Dis; 2013 Sep; 40(9):756-9. PubMed ID: 23949591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment failure with 2 g of azithromycin (extended-release formulation) in gonorrhoea in Japan caused by the international multidrug-resistant ST1407 strain of Neisseria gonorrhoeae.
    Morita-Ishihara T; Unemo M; Furubayashi K; Kawahata T; Shimuta K; Nakayama S; Ohnishi M
    J Antimicrob Chemother; 2014 Aug; 69(8):2086-90. PubMed ID: 24777907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergence and characterization of Neisseria gonorrhoeae isolates with decreased susceptibilities to ceftriaxone and cefixime in Canada: 2001-2010.
    Martin I; Sawatzky P; Allen V; Hoang L; Lefebvre B; Mina N; Wong T; Gilmour M
    Sex Transm Dis; 2012 Apr; 39(4):316-23. PubMed ID: 22421701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cefixime-resistant Neisseria gonorrhoeae in the UK: a time to reflect on practice and recommendations.
    Forsyth S; Penney P; Rooney G
    Int J STD AIDS; 2011 May; 22(5):296-7. PubMed ID: 21571983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cefixime and ceftriaxone susceptibility of Neisseria gonorrhoeae in Italy from 2006 to 2010.
    Carannante A; Prignano G; Cusini M; Matteelli A; Dal Conte I; Ghisetti V; D'Antuono A; Cavrini F; Antonetti R; Stefanelli P
    Clin Microbiol Infect; 2012 Jun; 18(6):558-64. PubMed ID: 21966997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ceftriaxone-Resistant Neisseria gonorrhoeae Isolates (2010 to 2014) in France Characterized by Using Whole-Genome Sequencing.
    de Curraize C; Kumanski S; Micaëlo M; Fournet N; La Ruche G; Meunier F; Amarsy R; Jacquier H; Cambau E; Goubard A; Bercot B
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6962-6964. PubMed ID: 27600036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of a Neisseria gonorrhoeae clone showing decreased susceptibility to cefixime in England and Wales.
    Chisholm SA; Alexander S; Desouza-Thomas L; Maclure-Webster E; Anderson J; Nichols T; Lowndes CM; Ison CA;
    J Antimicrob Chemother; 2011 Nov; 66(11):2509-12. PubMed ID: 21846672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.